Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of Central Sympathetic Nerve Ablation for Treatment of Ventricular Arrhythmias

NCT07501819 is registered in ClinicalTrials.gov with SymKardia as lead sponsor.

NCT NCT07501819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07501819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of Central Sympathetic Nerve Ablation for Treatment of Ventricular Arrhythmias
Lead sponsor
SymKardia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
September 30, 2027
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia (vt)